219 related articles for article (PubMed ID: 38144510)
1. Advances in Formulations of Microneedle System for Rheumatoid Arthritis Treatment.
Guo P; Huang C; Yang Q; Zhong G; Zhang J; Qiu M; Zeng R; Gou K; Zhang C; Qu Y
Int J Nanomedicine; 2023; 18():7759-7784. PubMed ID: 38144510
[TBL] [Abstract][Full Text] [Related]
2. Emerging trends in microneedle-based drug delivery strategies for the treatment of rheumatoid arthritis.
Gorantla S; Batra U; Puppala ER; Waghule T; Naidu VGM; Singhvi G
Expert Opin Drug Deliv; 2022 Apr; 19(4):395-407. PubMed ID: 35287532
[TBL] [Abstract][Full Text] [Related]
3. Polymer nanotherapeutics: A versatile platform for effective rheumatoid arthritis therapy.
Nooreen R; Nene S; Jain H; Prasannanjaneyulu V; Chitlangya P; Otavi S; Khatri DK; Raghuvanshi RS; Singh SB; Srivastava S
J Control Release; 2022 Aug; 348():397-419. PubMed ID: 35660632
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of drugs by adhesive transdermal patches equipped with dissolving microneedles for the treatment of rheumatoid arthritis.
Zheng L; Chen Y; Gu X; Li Y; Zhao H; Shao W; Ma T; Wu C; Wang Q
J Control Release; 2024 Jan; 365():274-285. PubMed ID: 37979695
[TBL] [Abstract][Full Text] [Related]
5. Polymeric microneedle-mediated transdermal delivery of melittin for rheumatoid arthritis treatment.
Du G; He P; Zhao J; He C; Jiang M; Zhang Z; Zhang Z; Sun X
J Control Release; 2021 Aug; 336():537-548. PubMed ID: 34237400
[TBL] [Abstract][Full Text] [Related]
6. Can pyroptosis be a new target in rheumatoid arthritis treatment?
Wu D; Li Y; Xu R
Front Immunol; 2023; 14():1155606. PubMed ID: 37426634
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review of advanced drug delivery systems for the treatment of rheumatoid arthritis.
Shen Q; Du Y
Int J Pharm; 2023 Mar; 635():122698. PubMed ID: 36754181
[TBL] [Abstract][Full Text] [Related]
8. [Application of microneedle-assisted percutaneous drug delivery system in treatment of rheumatoid arthritis:a review].
Liang X; Li YL; Zhang JH; Bai HT; Sun SH; Zhang QQ; Yang J; Wang R
Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(1):13-21. PubMed ID: 36725253
[TBL] [Abstract][Full Text] [Related]
9. Dissolving microneedle patch-assisted transdermal delivery of methotrexate improve the therapeutic efficacy of rheumatoid arthritis.
Zhao W; Zheng L; Yang J; Ma Z; Tao X; Wang Q
Drug Deliv; 2023 Dec; 30(1):121-132. PubMed ID: 36533887
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol nanocrystals based dissolving microneedles with highly efficient for rheumatoid arthritis.
Diao N; Liu Y; Wang W; Cao M; Liu X; Yang W; Cao Y; Sun T; Pei H; Guo C; Chen D
Drug Deliv Transl Res; 2024 Mar; ():. PubMed ID: 38556538
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine for the Treatment of Rheumatoid Arthritis.
Jeong M; Park JH
Mol Pharm; 2021 Feb; 18(2):539-549. PubMed ID: 32502346
[TBL] [Abstract][Full Text] [Related]
12. Flexible two-layer dissolving and safing microneedle transdermal of neurotoxin: A biocomfortable attempt to treat Rheumatoid Arthritis.
Yao W; Tao C; Zou J; Zheng H; Zhu J; Zhu Z; Zhu J; Liu L; Li F; Song X
Int J Pharm; 2019 May; 563():91-100. PubMed ID: 30890451
[TBL] [Abstract][Full Text] [Related]
13. Pain Management Strategies in Rheumatoid Arthritis: A Narrative Review.
Sánchez-Flórez JC; Seija-Butnaru D; Valero EG; Acosta CDPA; Amaya S
J Pain Palliat Care Pharmacother; 2021 Dec; 35(4):291-299. PubMed ID: 34623946
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic delivery systems for rheumatoid arthritis based on hydrogel carriers.
Chapa-Villarreal FA; Stephens M; Pavlicin R; Beussman M; Peppas NA
Adv Drug Deliv Rev; 2024 May; 208():115300. PubMed ID: 38548104
[TBL] [Abstract][Full Text] [Related]
15. Transdermal delivery of inflammatory factors regulated drugs for rheumatoid arthritis.
Zhang Y; Gao Z; Chao S; Lu W; Zhang P
Drug Deliv; 2022 Dec; 29(1):1934-1950. PubMed ID: 35757855
[TBL] [Abstract][Full Text] [Related]
16. Dissolving microneedle patches-mediated percutaneous delivery of tetramethylpyrazine for rheumatoid arthritis treatment.
Zhao W; Zheng L; Yang J; Li Y; Zhang Y; Ma T; Wang Q
Eur J Pharm Sci; 2023 May; 184():106409. PubMed ID: 36871810
[TBL] [Abstract][Full Text] [Related]
17. Treatment of rheumatoid arthritis.
Gaffo A; Saag KG; Curtis JR
Am J Health Syst Pharm; 2006 Dec; 63(24):2451-65. PubMed ID: 17158693
[TBL] [Abstract][Full Text] [Related]
18. Targeted drug-delivery systems in the treatment of rheumatoid arthritis: recent advancement and clinical status.
Gorantla S; Singhvi G; Rapalli VK; Waghule T; Dubey SK; Saha RN
Ther Deliv; 2020 Apr; 11(4):269-284. PubMed ID: 32434463
[TBL] [Abstract][Full Text] [Related]
19. What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis.
Simpson E; Hock E; Stevenson M; Wong R; Dracup N; Wailoo A; Conaghan P; Estrach C; Edwards C; Wakefield R
Health Technol Assess; 2018 Apr; 22(20):1-258. PubMed ID: 29712616
[TBL] [Abstract][Full Text] [Related]
20. Novel drug delivery systems for NSAIDs in management of rheumatoid arthritis: An overview.
Thakur S; Riyaz B; Patil A; Kaur A; Kapoor B; Mishra V
Biomed Pharmacother; 2018 Oct; 106():1011-1023. PubMed ID: 30119166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
